Researchers looked into the relationship between Hashimoto’s disease and papillary thyroid cancer in a study that included 2,821 subjects with papillary thyroid cancer and 653 Hashimoto’s patients.
According to their report at the 2011 meeting of the American Thyroid Association, 58 percent of the patients with thyroid cancer also had Hashimoto’s disease.
Compared to those subjects that had Hashimoto’s disease without papillary thyroid cancer, the Hashimoto’s/papillary thyroid cancer group had higher thyroid stimulating hormone (TSH) levels.
Another study found that a TSH of 2.5 mIU/L or higher was associated with higher risk of thyroid cancer in children.
Though this association does not prove causation, it provides the groundwork for future research to see if Hashimoto’s disease is a precursor to thyroid cancer.
Thyroid cancer is the fastest growing cancer in the United States, and Hashimoto’s disease is increasing at epidemic rates. What’s more, Hashimoto’s and thyroid cancer are both related to iodine deficiency.
My experience has shown that correcting iodine deficiency as part of a holistic treatment regimen can help a patient overcome Hashimoto’s disease. When TSH levels rise (within the reference range) it can be a signal for future problems.
Early action on this rising TSH level may prevent future illnesses.
More information about this can be found in my books, Iodine: Why You Need It, Why You Can’t Live Without It and Overcoming Thyroid Disorders.
© 2022 NewsmaxHealth. All rights reserved.